Bank of America
INAB icon

Bank of America’s IN8bio INAB Stock Holding History

Bank of America’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37
Closed -$87 – 6279
2025
Q4 		$87 Buy
37
+1
+3% +$2 ﹤0.01% 6846
2025
Q3 		$78 Buy
36
+12
+50% +$26 ﹤0.01% 7907
2025
Q2 		$50 Buy
24
+8
+50% +$33 ﹤0.01% 8104
2025
Q1 		$81 Buy
16
+1
+7% +$8 ﹤0.01% 7871
2024
Q4 		$118 Buy
15
+1
+7% +$9 ﹤0.01% 7705
2024
Q3 		$113 Buy
14
+5
+56% +$91 ﹤0.01% 7697
2024
Q2 		$225 Buy
+9
New +$289 ﹤0.01% 7536
2024
Q1 		– Hold
0
– -$18 – 7945
2023
Q4 		– Hold
0
– – – 7664
2023
Q2 		– Sell
-1
Closed -$50 – 7816
2023
Q1 		$50 Hold
1
– – ﹤0.01% 7521
2022
Q4 		$46 Buy
+1
New +$56 ﹤0.01% 7814
2022
Q1 		– Hold
0
– – – 8489
2021
Q4 		– Hold
0
– – – 8398

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Bank of America's INAB Position: Q1 2026 in Review

Bank of America sold out of IN8bio (INAB) in Q1 2026, closing a stake of 37 shares — an estimated $87 sold.

Bank of America first reported a position in INAB in Q4 2022 and held it in 9 quarters. The position peaked at $225 in Q2 2024. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

  • Bank of America reported no remaining IN8bio position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 37 IN8bio shares in Q1 2026, an estimated $87.
  • Bank of America first reported a position in IN8bio in Q4 2022 and held it in 9 quarters.
  • Bank of America's IN8bio position peaked at $225 in Q2 2024.
  • 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.